EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
CV Sciences, Inc. (CVSI) had EBITDA Margin of 1.70% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$13.79M |
|
$-0.96M |
|
$7.04M |
|
$6.75M |
|
$14.26M |
|
$-0.47M |
|
$-0.48M |
|
$-0.95M |
|
$-0.95M |
|
$-0.96M |
|
$-0.96M |
|
$-0.96M |
|
$-0.96M |
|
$-0.47M |
|
$0.23M |
|
184.26M |
|
184.26M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$5.13M |
|
$0.34M |
|
$1.83M |
|
$6.96M |
|
$5.00M |
|
$0.39M |
|
$0.49M |
|
$5.49M |
|
$1.47M |
|
$0.38M |
|
$1.47M |
|
184.26M |
|
| Cash Flow Statement Financials | |
$-0.41M |
|
$-0.11M |
|
$0.34M |
|
$0.45M |
|
$0.28M |
|
$-0.18M |
|
$0.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.03 |
|
-- |
|
-- |
|
0.21 |
|
1.12 |
|
48.97% |
|
-3.41% |
|
-3.41% |
|
|
EBITDA Margin |
1.70% |
-6.88% |
|
-6.95% |
|
$-0.52M |
|
-- |
|
-- |
|
-- |
|
1.98 |
|
1.72 |
|
34.30 |
|
10.64 |
|
-65.26% |
|
-254.11% |
|
-13.76% |
|
-51.64% |
|
$0.01 |
|
$-0.00 |
|
$-0.00 |
|